Resistance to fucidic acid in clinical Staphylococcus aureus isolates

Basit Öğe Kaydı
dc.contributor.authorCelen, Mustafa Kemal
dc.contributor.authorAyaz, Celal
dc.contributor.authorOzmen, Esen
dc.contributor.authorGeyik, M. Faruk
dc.contributor.authorHosoglu, Salih
dc.date.accessioned2024-04-24T17:44:41Z
dc.date.available2024-04-24T17:44:41Z
dc.date.issued2005
dc.departmentDicle Üniversitesien_US
dc.description.abstractFusidic acid derived from Fusidium coccineum is an antibiotic which inhibites protein synthesis of bacteria and has been used in Turkey since the beginning of 1998. In vitro activity of fusidic acid was investigated in 69 methicillin-resistant Staphylococcus aureus (MRSA) and 56 methicillin-sensitive S. aureus (MSSA) isolates by disk diffusion method. Fusidic acid resistance was found 20.3 % in MRSA strains and 3.6 % in MSSA strains by disk diffusion test. In our country fusidic acid preserves its state of being an empirical antimicrobial agent in a combination therapy by its lower resistance rates and it is a preferred peroral drug in middle and mild staphylococcal infections of outpatient clinics.en_US
dc.identifier.endpage116en_US
dc.identifier.issn1301-143X
dc.identifier.issn1309-1484
dc.identifier.issue3en_US
dc.identifier.startpage114en_US
dc.identifier.urihttps://hdl.handle.net/11468/22232
dc.identifier.volume18en_US
dc.identifier.wosWOS:000420790000006
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isotren_US
dc.publisherAvesen_US
dc.relation.ispartofKlimik Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectStaphylococcus Aureusen_US
dc.subjectFusidic Aciden_US
dc.subjectMrsaen_US
dc.subjectMssaen_US
dc.titleResistance to fucidic acid in clinical Staphylococcus aureus isolatesen_US
dc.titleResistance to fucidic acid in clinical Staphylococcus aureus isolates
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu